Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Gary Mohilner who wrote (2981)	4/3/2000 10:21:00 PM
From: Chi Wong	Read Replies (1) \| Respond to of 5665

From where I sit, I think the best way to think about IMGN is that we won't get very much press from the clinic but we could certainly infer what's happening if there are: 1) one or more TAP partnerships 2) announcement of Accelerated phase III There is currently so much going on at IMGN that I can't seem to keep track of what's expected and what's going on at the company. I believe we still have a bigger market cap than NERX which currently has a drug in phase III testing seems significant to me somehow. ramble mode off.